The emerging bioprocess automation software market offers opportunities in enhancing biomanufacturing efficiency and consistency through digitalization. Demand is bolstered by the need for real-time ...

Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...

The initial promise of LLMs as a total fix for enterprise automation has stalled. We have solved for reasoning at scale, but turning that reasoning into real-world results is a different story. We ...

G2’s Winter 2026 report highlights growing adoption of AI-driven automation testing tools, reflecting how user feedback is shaping enterprise QA and testing decisions.